Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Norway

PMID:14568978  

Msh2 ATPase activity is essential for somatic hypermutation at a-T basepairs and for efficient class switch recombination.

Alberto Martin | Ziqiang Li | Diana P Lin | Philip D Bardwell | Maria D Iglesias-Ussel | Winfried Edelmann | Matthew D Scharff
The Journal of experimental medicine | 2003

Somatic hypermutation (SHM) and class switch recombination (CSR) are initiated by activation-induced cytidine deaminase-mediated cytidine deamination of immunoglobulin genes. MutS homologue (Msh) 2-/- mice have reduced A-T mutations and CSR. This suggests that Msh2 may play a role in repairing activation-induced cytidine deaminase-generated G-U mismatches. However, because Msh2 not only initiates mismatch repair but also has other functions, such as signaling for apoptosis, it is not known which activity of Msh2 is responsible for the effects observed, and consequently, many models have been proposed. To further dissect the role of Msh2 in SHM and CSR, mice with a "knockin" mutation in the Msh2 gene that inactivates the adenosine triphosphatase domain were examined. This mutation (i.e., Msh2G674A), which does not affect apoptosis signaling, allows mismatches to be recognized but prevents Msh2 from initiating mismatch repair. Here, we show that, similar to Msh2-/- mice, SHM in Msh2G674A mice is biased toward G-C mutations. However, CSR is partially reduced, and switch junctions are more similar to those of postmeiotic segregation 2-/- mice than to Msh2-/- mice. These results indicate that Msh2 adenosine triphosphatase activity is required for A-T mutations, and suggest that Msh2 has more than one role in CSR.

Pubmed ID: 14568978

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: T32 CA009173
  • Agency: NCI NIH HHS, United States
    Id: 5T32 CA09173
  • Agency: NCI NIH HHS, United States
    Id: R01 CA093484
  • Agency: NIAID NIH HHS, United States
    Id: AI43937
  • Agency: NCI NIH HHS, United States
    Id: R01 CA076329
  • Agency: NCI NIH HHS, United States
    Id: R01 CA102705
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI043937
  • Agency: NCI NIH HHS, United States
    Id: CA102705
  • Agency: NCI NIH HHS, United States
    Id: R01 CA072649
  • Agency: NCI NIH HHS, United States
    Id: CA93484
  • Agency: NCI NIH HHS, United States
    Id: CA72649
  • Agency: NCI NIH HHS, United States
    Id: CA76329

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions